Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06506058 · ClinicalTrials.gov registry record · NA

Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT06506058: Recruiting NA study of Parkinson Disease, sponsored by University of Minnesota.

NCT06506058 is a NA study of Parkinson Disease that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 75 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06506058, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Currently, there is a lack of comprehensive knowledge about the role of vestibulospinal drive and cortical activity during self-initiated movement transitions in older adults and people with PD (both with and without FOG). This set of experiments has two primary purposes: to (1) understand the pathological neurophysiology underlying freezing of gait (FOG) during movement transitions and FOG-inducing movements and (2) identify neurological biomarkers associated with FOG and FOG-inducing movements. To achieve this, the investigators will assess vestibular activity using the noninvasive neuromodulation technique of electrical vestibular stimulation (EVS, Experiments 1 and 2) and assess cortical activity by recording via electroencephalography (EEG, Experiments 3 and 4, no stimulation included). These experiments will investigate the vestibular (EVS Experiments) and cortical (EEG experiments) contributions to movement transitions during standing, walking, turning, and changing movement rates. Upon completion of this project, the investigators expect to provide a new understanding of key neural systems (vestibular and cortical) involved in the pathogenesis of movement impairment and freezing episodes during movement transitions including gait initiation, turning, and changing movement rates, in people with PD. An increased understanding of the temporal dynamics of systems involved in FOG and FOG-inducing movements could later guide the development and delivery of novel interventions (e.g. closed-loop deep brain stimulation \[DBS\] or non-invasive brain stimulation) to decrease the incidence and severity of FOG episodes, reducing fall risk and morbidity.

Primary Outcome

Onset and offset times of the trunk muscle activity, relative to the start of the turn, as measured by electromyography sensors

Conditions Studied

Interventions

  • DEVICE EVS and EEG

Study Locations (1)

Minnesota

  • University of Minnesota, Movement Disorders Lab - Minneapolis

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2025-03-24
Est. Completion 2029-01-01
Phase NA
University of Minnesota

966 total trials

What NCT06506058 shows while recruiting

NCT06506058 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which EVS and EEG is the first listed.

NCT06506058 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06506058 about?

NCT06506058 is a clinical study titled "Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease". Currently, there is a lack of comprehensive knowledge about the role of vestibulospinal drive and cortical activity during self-initiated movement transitions in older adults and people with PD (both with and without FOG). This set of experiments has two primary purposes: to (1) understand the patho...

What is the current status of trial NCT06506058?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-03-24. Estimated completion is 2029-01-01.

What conditions does trial NCT06506058 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06506058?

The interventions under investigation include: EVS and EEG (DEVICE).

Who is sponsoring clinical trial NCT06506058?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06506058 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06506058's enrollment target sits among peer trials

75 112th of 297 higher than 183 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06506058, the US trial registry maintained by the National Library of Medicine. NCT06506058 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.